NL-OMON23587
招募中
不适用
Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation.
eiden University Medical CenterDutch MEN-1 Study Group0 个研究点目标入组 30 人待定
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- MEN-1Primary HyperparathyroidismPrimair HyperparathyreoidieCinacalcetCaSR
- 发起方
- eiden University Medical CenterDutch MEN-1 Study Group
- 入组人数
- 30
- 状态
- 招募中
- 最后更新
- 2年前
概览
简要总结
/A
研究者
入排标准
入选标准
- •A diagnosis of primary hyperparathyroidism due to a genetically confirmed germline mutation in the MEN\-1 gene.
排除标准
- •1\. Sporadic primary hyperparathyroidism;
- •2\. Autonomous hyperparathyroidism due to chronic renal failure or vitamin D deficiency;
结局指标
主要结局
未指定
相似试验
已完成
不适用
Efficacy of cinacalcet in hyperparathyroidism after renal transplantation.open label observational study during 8 months in approx 20 renal transplant patientsNL-OMON24309Renal Transplant UnitAcademic Medical Center20
进行中（未招募）
不适用
Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPTPatients with primary hyperparathyroidism due to a germline mutation in the MEN-1 geneMedDRA version: 12.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidismEUCTR2010-018861-53-NLeiden University Medical Center
已完成
4 期
Efficacy and safety of treatment with Cinacalcet in patients with Primary Hyperparathyroidism due to a MEN-1 mutatiohyperactive parathyroid glandsprimary hyperparathyroidism1008362410033949NL-OMON34871eids Universitair Medisch Centrum20
已完成
4 期
Efficacy of Cinacalcet in the Control of Primary HyperparathyroidismHyperparathyroidism, PrimaryOsteoporosisNCT02417389Istituto Auxologico Italiano22
进行中（未招募）
不适用
Assess the stability / benefit of Cinacalcet treatment over conventional therapy based on bone metabolism, arterial stiffness and vascular calcification in advanced chronic renal failureBone's disorders and mineral metabolism and vascular involvementMedDRA version: 16.1Level: PTClassification code 10051753Term: Vascular calcificationSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Body processes [G] - Metabolic Phenomena [G03]EUCTR2013-002270-52-ESHospital Universitari de Girona Dr.Josep Trueta